Latest Myosarcoma Stories
Rhabdomyosarcoma (RMS) is an aggressive muscle cancer that mostly affects children.
CALGARY, Nov. 14 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr.
ImClone Systems has announced that a Phase II clinical trial of IMC-A12, the company's fully human, IgG1 anti-insulin-like growth factor-1 receptor monoclonal antibody, in adolescents and adult patients with several types of soft tissue sarcoma has opened for patient enrollment.
After 63-year-old Brooke Zepp was diagnosed with leiomyosarcoma, a rare life-threatening form of cancer in her abdomen, her doctors faced the daunting challenge of removing a total of six organs in order to take out the tumor, which was wrapped around her aorta and the base of two other arteries.